US extends review of Roche MS drug Ocrevus by three months
US extends review of Roche MS drug Ocrevus by three months
The U.S. Food and Drug Administration (FDA) has extended its review of Roche's multiple sclerosis drug Ocrevus by three months to March 28, the Swiss drugmaker said recently...Read more - http://www.ms-uk.org/us-extends-review- ... ths-231216
MS-UK - http://www.ms-uk.org/